Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113024554A reveals a novel one-pot cyclization for Lumateperone intermediates, offering significant cost reduction and scalable manufacturing advantages for pharmaceutical supply chains.
Patent CN114957030B reveals Rhodococcus erythropolis AJ270 catalyzed hydrolysis for high-purity chiral intermediates, offering cost reduction and supply chain reliability.
Patent CN101177398B details a novel purification method for Triflusal, achieving >99.5% purity via alkaline dissolution and THF/cyclohexane recrystallization, ensuring supply chain stability.
Patent CN108558692A reveals mild NHC-catalyzed amide synthesis. Offers high purity, cost reduction in pharmaceutical intermediates manufacturing, and scalable supply chain solutions.
Patent CN103665038A details a room-temperature synthesis of (RP)-menthylphenylphosphine oxide, offering a cost-effective route for high-purity chiral ligand precursors.
Novel patent CN105131017B offers high-purity antibiotic intermediate synthesis with improved yield and reduced impurities for reliable supply chain partners.
Patent CN112479853B reveals a novel resin-catalyzed route for D-2-chloropropionyl chloride, offering high purity and cost reduction in API manufacturing without rectification towers.
Patent CN110294712B reveals a novel two-step synthesis for high-purity imidazole acetate ionic liquids, offering >99% purity and minimal halide residues for industrial applications.
Patent CN112159336B reveals a metal-free route for aryne-substituted nitriles, offering high purity and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN105777592B reveals high-yield synthesis for nitro sulphonyl compounds. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN105017181A reveals a cost-effective route for Carfilzomib intermediates. Discover high-purity manufacturing solutions and supply chain advantages for proteasome inhibitors.
Patent CN112703179A details a safe, solvent-free nitration process for 3-NOP, offering significant cost reduction and supply chain stability for global manufacturers.
Patent CN105039432A details Penicillium biocatalysis for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN107778241B details a metal-free route for dihydrophenanthridines, offering cost-effective manufacturing and simplified supply chains for pharma intermediates.
Patent CN105177069A details high-yield biocatalysis for chiral intermediates. Offers sustainable manufacturing and supply chain reliability for global pharmaceutical partners.
Patent CN1798726A reveals a mild palladium-catalyzed reductive cyclization for indoles, offering significant cost reduction and supply chain reliability for API intermediates.
Novel patent CN100434429C details a cleaner route for 2-arylimidazo[2,1-a]isoquinoline, offering cost-effective manufacturing and reduced environmental impact for contraceptive drug production.
Patent CN105087668A reveals high-yield biocatalytic route for chiral intermediates. Achieve cost reduction and supply reliability with green manufacturing processes.
Patent CN105039435A details yeast biocatalysis for high-purity chiral intermediates. Achieve significant cost reduction and supply chain reliability with scalable green manufacturing.
Patent CN119120437A reveals high-efficiency enzyme mutants for tyrosine derivatives. Achieves 160g/L concentration and 99.9% purity, offering significant supply chain and cost advantages for manufacturers.